HMPL-504

HMPL-504 · Hutchison Medipharma Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HMPL-504, covering 2021-11-30 to 2021-11-30. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma and Other Non-small Cell Lung Cancer [Phase 2]